Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

One of the key findings in recent studies is the role of glucagon-like peptide-1 (GLP-1) in postprandial hypoglycemia. After bariatric surgery, the body often experiences an exaggerated release of ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...

Bariatric surgery is currently the most ... treatment of diabetes and obesity is currently limited. The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

PBH is a condition characterized by repeated hypoglycemic episodes following bariatric surgery due to exaggerated ... long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist, being ...

A new study reports that GLP-1 medications may provide benefits ... medical director of Bariatric and Robotic Surgery at Hackensack Meridian Jersey Shore University Medical Center in New Jersey ...